Trials / Completed
CompletedNCT04217291
The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus
Evaluation of the Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Suzhou Yabao Pharmaceutical R&D Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study in patients with type 2 diabetes mellitus (T2DM).
Detailed description
200 cases will be included and divided into four groups with 50 cases in each group
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SY-004 | Take orally once a day |
| OTHER | SY-004 matching placebo | Take orally once a day |
Timeline
- Start date
- 2019-12-10
- Primary completion
- 2021-07-09
- Completion
- 2021-07-09
- First posted
- 2020-01-03
- Last updated
- 2022-05-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04217291. Inclusion in this directory is not an endorsement.